Cargando…
Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use
BACKGROUND: Antimicrobial resistance (AMR) poses a colossal threat to global health and incurs high economic costs to society. Economic evaluations of antimicrobials and interventions such as diagnostics and vaccines that affect their consumption rarely include the costs of AMR, resulting in sub-opt...
Autores principales: | Shrestha, Poojan, Cooper, Ben S., Coast, Joanna, Oppong, Raymond, Do Thi Thuy, Nga, Phodha, Tuangrat, Celhay, Olivier, Guerin, Philippe J., Wertheim, Heiman, Lubell, Yoel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085682/ https://www.ncbi.nlm.nih.gov/pubmed/30116525 http://dx.doi.org/10.1186/s13756-018-0384-3 |
Ejemplares similares
-
C-reactive protein point of care testing in the management of acute respiratory infections in the Vietnamese primary healthcare setting – a cost benefit analysis
por: Lubell, Yoel, et al.
Publicado: (2018) -
How context can impact clinical trials: a multi-country qualitative case study comparison of diagnostic biomarker test interventions
por: Haenssgen, Marco J., et al.
Publicado: (2019) -
Economic considerations support C-reactive protein testing alongside malaria rapid diagnostic tests to guide antimicrobial therapy for patients with febrile illness in settings with low malaria endemicity
por: Lubell, Yoel, et al.
Publicado: (2019) -
Malaria and Economic Evaluation Methods: Challenges and Opportunities
por: Drake, Tom L., et al.
Publicado: (2017) -
Malaria eradication: the economic, financial and institutional challenge
por: Mills, Anne, et al.
Publicado: (2008)